- $1.22bn
- $1.27bn
- $606.88m
Brief: Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health
Brief: OPKO Health Q2 Net Income USD -10.3 Million
Opko Health Inc Expected To Post A Loss Of 9 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Allstate, Quanta, First Industrial Realty
U.S. STOCKS ON THE MOVE-Meta Platforms, Cintas, Toast
Opko Health climbs on stock buyback plan
Brief: OPKO Health Announces $100 Million Share Repurchase Program
U.S. RESEARCH ROUNDUP-Elevance Health, J&J, Primerica
Factbox: Weight-loss drug developers line up to tap market worth $150 billion
Factbox: Weight-loss drug developers hoping to join potential $100 bln market
Opko Health Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: OPKO Health Q1 Net Income USD -81.8 Million
Opko Health Inc Expected To Post A Loss Of 9 Cents A Share: Earnings Preview
Opko Health Inc Expected To Post A Loss Of 9 Cents A Share: Earnings Preview
Labcorp to buy select assets of OPKO Health's unit; OPKO shares up
Factbox: Novo Nordisk brings new contender in race for blockbuster obesity drugs
Brief: AIDS Clinical Trial Presents Results From Phase 1 Study Of ModeX Trispecific Antibody For HIV Prevention, Treatment
Opko Health Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: OPKO Health Q4 Net Income USD -65.5 Million